T. Rowe Price Associates’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.81M | Buy |
49,284
+3,527
| +8% | +$130K | ﹤0.01% | 1681 |
|
2025
Q1 | $1.8M | Buy |
45,757
+4,356
| +11% | +$171K | ﹤0.01% | 1652 |
|
2024
Q4 | $1.92M | Buy |
41,401
+5,554
| +15% | +$258K | ﹤0.01% | 1659 |
|
2024
Q3 | $1.62M | Buy |
35,847
+1,100
| +3% | +$49.7K | ﹤0.01% | 1739 |
|
2024
Q2 | $1.71M | Buy |
34,747
+2,620
| +8% | +$129K | ﹤0.01% | 1633 |
|
2024
Q1 | $1.1M | Buy |
32,127
+2,292
| +8% | +$78.7K | ﹤0.01% | 1869 |
|
2023
Q4 | $1.1M | Sell |
29,835
-530,122
| -95% | -$19.5M | ﹤0.01% | 1824 |
|
2023
Q3 | $11.3M | Sell |
559,957
-21,683
| -4% | -$439K | ﹤0.01% | 1052 |
|
2023
Q2 | $11.9M | Buy |
581,640
+180,411
| +45% | +$3.69M | ﹤0.01% | 1046 |
|
2023
Q1 | $6.05M | Sell |
401,229
-323,023
| -45% | -$4.87M | ﹤0.01% | 1141 |
|
2022
Q4 | $17.2M | Sell |
724,252
-86,971
| -11% | -$2.07M | ﹤0.01% | 951 |
|
2022
Q3 | $28.6M | Sell |
811,223
-447,171
| -36% | -$15.8M | ﹤0.01% | 796 |
|
2022
Q2 | $44M | Buy |
1,258,394
+120,489
| +11% | +$4.21M | 0.01% | 914 |
|
2022
Q1 | $56.2M | Buy |
1,137,905
+222,676
| +24% | +$11M | 0.01% | 932 |
|
2021
Q4 | $70.8M | Sell |
915,229
-123,529
| -12% | -$9.56M | 0.01% | 877 |
|
2021
Q3 | $111M | Sell |
1,038,758
-5,998
| -0.6% | -$642K | 0.01% | 732 |
|
2021
Q2 | $139M | Buy |
1,044,756
+86,849
| +9% | +$11.6M | 0.01% | 671 |
|
2021
Q1 | $119M | Sell |
957,907
-13,070
| -1% | -$1.62M | 0.01% | 718 |
|
2020
Q4 | $137M | Buy |
970,977
+317,301
| +49% | +$44.8M | 0.01% | 621 |
|
2020
Q3 | $49.7M | Buy |
653,676
+174,094
| +36% | +$13.2M | 0.01% | 874 |
|
2020
Q2 | $21.7M | Buy |
479,582
+472,790
| +6,961% | +$21.4M | ﹤0.01% | 1119 |
|
2020
Q1 | $208K | Buy |
+6,792
| New | +$208K | ﹤0.01% | 2305 |
|